Medical Technology News

Genetic Testing Market Size Garner USD 17.89 billion by 2026

Press release   •   Sep 26, 2019 11:25 EDT

The Global Genetic Testing Market is estimated to grow at CAGR above 11.1 % over the forecast time frame 2019-2026 and reach the market value around USD 17.89 billion by 2026.

Genetic testing is the study of the cells and tissues contained in the gene. In the field of biology and medicine, this study is further implemented to get a better understanding of genetic disorders like cancer, cystic fibrosis, sickle cell anemia, Down syndrome, and others. The report's scope explores the use of gene testing for personalized medicine growth, targeted cancer therapy, and other genetic illnesses.

Novel genetic testing technologies, together with increasing efficiency and accuracy are providing lucrative growth opportunities for the genetic testing market. Furthermore, across the emerging economies, the market is expected to witness exponential growth rates owing to the growing patient ratio and awareness. One of the major trends moving across the genetic testing industry includes the shifting focus on clinical science to bioinformatics.

Get Free Sample Pages for more Understanding@ https://www.visionresearchreports.com/report/sample/28947

In the near future, the global genetic testing market is anticipated to record significant development owing to an increase in the incidence of genetic disorders & cancer and an increase in awareness and acceptance of personalized drugs. Additionally, advances in genetic testing methods and the growing application of genetic testing in oncology are anticipated to grow significantly over the coming years.

The report analyzes and forecasts the genetic testing market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report comprises a detailed value chain analysis, which provides a comprehensive view of the global genetic testing market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view of the genetic testing market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The report provides size (in terms of volume and value) of genetic testing market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

Request to Buy This Premium Report From here@ https://www.visionresearchreports.com/report/cart/28947

Key Players & Strategies

23andMe, Abbott Molecular, Biocartis, BioHelix, Bayer Diagnostics, BioMerieux, BGI, Celera Genomics, Cepheid, Counsyl, deCODEme, Genentech, Genomictree, HTG Molecular Diagnostics, Luminex, MolecularTM, IntegraGen, LabCorp diagnostics, Myriad, Natera, PacBio, Pathway Geneomaics, Qiagen, Roche Diagnostic is among the most eminent players in the global genetic testing market. Industry players focus on the strategic expansion of their product portfolio through acquisitions, fusions and collaborations. Roche, for example, in December 2018, acquired the Non-invasive Prenatal (NIPT) and cell-free DNA testing services market Ariosa Diagnostics, a provider of molecular diagnostic testing services.

The increasing prevalence in the genetic testing industry will drive a growing global genetic testing industry for diseases like cancer, cystic fibrosis, Alzheimer's and others. Increasing genetical tests and genetic mutation identification before their onset will further increase the industry's growth over the forecast period. Due to the increased adoption of genetic testing by physicians in clinical care, the industry should see rapid growth in future. The availability of direct consumer (DTC) regulatory aid and on-going technological advances allow industry players to maintain a position on the market.

Market Segmentation

Global Genetic Testing Market, by Type

  • Predictive Testing
  • Prenatal & Newborn Testing
  • Diagnostic Testing
  • Carrier Testing
  • Pharmacogenomic Testing
  • Others

Global Genetic Testing Market, by Technology

  • Biochemical Testing
  • Cytogenetic Testing/ Chromosome Analysis
  • Molecular Testing
    • DNA Sequencing
    • Others

Global Genetic Testing Market, by Application

  • Genetic Disease Diagnosis
  • Cardiovascular Disease Diagnosis
  • Chromosome Analysis
  • Others

Global Genetic Testing Market, by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.

Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.

The study objectives of this report are:

  • To analyze and study the global genetic testing capacity, production, value, consumption, status (2014-2018) and forecast (2019-2026);
  • Focuses on the key genetic testing manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Request to Buy This Premium Report From here@ https://www.visionresearchreports.com/report/cart/28947

Table of Content

Section 1. INDUSTRY OVERVIEW

1.1. Market Definition and Scope
1.1.1. Market Definition of Genetic Testing
1.1.2. Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Genetic Testing Market By Type
1.2.2.1. Global Genetic Testing Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.2.2. Global Genetic Testing Market Revenue Share By Type in 2017
1.2.2.3. Predictive Testing
1.2.2.4. Prenatal & Newborn Testing
1.2.2.5. Diagnostic Testing
1.2.2.6. Carrier Testing
1.2.2.7. Pharmacogenomic Testing
1.2.2.8. Others
1.2.3. Genetic Testing Market By Technology
1.2.3.1. Global Genetic Testing Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.2. Global Genetic Testing Market Revenue Share By Technology in 2017
1.2.3.3. Biochemical Testing
1.2.3.4. Cytogenetic Testing/ Chromosome Analysis
1.2.3.5. Molecular Testing
1.2.3.6. DNA Sequencing
1.2.3.7. Others
1.2.4. Genetic Testing Market By Application
1.2.4.1. Global Genetic Testing Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Global Genetic Testing Market Revenue Share By Application in 2017
1.2.4.3. Genetic Disease Diagnosis
1.2.4.4. Cardiovascular Disease Diagnosis
1.2.4.5. Chromosome Analysis
1.2.4.6. Others
1.2.5. Genetic Testing Market by Geography
1.2.5.1. Global Genetic Testing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Genetic Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Genetic Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Genetic Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Genetic Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Genetic Testing Market Revenue and Growth Rate (2015-2026)

Section 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

Section 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Genetic Testing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Genetic Testing Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Genetic Testing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Genetic Testing Major Manufacturers in 2017

Section 4. GENETIC TESTING MARKET BY TYPE

4.1. Global Genetic Testing Revenue By Type
4.2. Predictive Testing
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Prenatal & Newborn Testing
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Diagnostic Testing
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Carrier Testing
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Pharmacogenomic Testing
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Others
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

Section 5. GENETIC TESTING MARKET BY TECHNOLOGY

5.1. Global Genetic Testing Revenue By Technology
5.2. Biochemical Testing
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Cytogenetic Testing/ Chromosome Analysis
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Molecular Testing
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. DNA Sequencing
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Others
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

Section 6. GENETIC TESTING MARKET BY APPLICATION

6.1. Global Genetic Testing Revenue By Application
6.2. Genetic Disease Diagnosis
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Cardiovascular Disease Diagnosis
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Chromosome Analysis
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

Section 7. NORTH AMERICA GENETIC TESTING MARKET BY COUNTRY

7.1. North America Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Genetic Testing Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

Section 8. EUROPE GENETIC TESTING MARKET BY COUNTRY

8.1. Europe Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

Section 9. ASIA-PACIFIC GENETIC TESTING MARKET BY COUNTRY

9.1. Asia-Pacific Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

Section 10. LATIN AMERICA GENETIC TESTING MARKET BY COUNTRY

10.1. Latin America Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

Section 11. MIDDLE EAST GENETIC TESTING MARKET BY COUNTRY

11.1. Middle East Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

Section 12. AFRICA GENETIC TESTING MARKET BY COUNTRY

12.1. Africa Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

Section 13. COMPANY PROFILE

13.1. 23andMe
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Abbott Molecular
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Biocartis
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. BioHelix
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Bayer Diagnostics
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. BioMerieux
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. BGI
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Celera Genomics
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Cepheid
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Counsyl
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Product Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. deCODEme
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Product Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. Genentech
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Product Portfolio
13.12.5. Key Developments
13.12.6. Strategies
13.13. Genomictree
13.13.1. Company Snapshot
13.13.2. Overview
13.13.3. Financial Overview
13.13.4. Product Portfolio
13.13.5. Key Developments
13.13.6. Strategies
13.14. HTG Molecular Diagnostics
13.14.1. Company Snapshot
13.14.2. Overview
13.14.3. Financial Overview
13.14.4. Product Portfolio
13.14.5. Key Developments
13.14.6. Strategies
13.15. Luminex
13.15.1. Company Snapshot
13.15.2. Overview
13.15.3. Financial Overview
13.15.4. Product Portfolio
13.15.5. Key Developments
13.15.6. Strategies
13.16. MolecularMD
13.16.1. Company Snapshot
13.16.2. Overview
13.16.3. Financial Overview
13.16.4. Product Portfolio
13.16.5. Key Developments
13.16.6. Strategies
13.17. IntegraGen
13.17.1. Company Snapshot
13.17.2. Overview
13.17.3. Financial Overview
13.17.4. Product Portfolio
13.17.5. Key Developments
13.17.6. Strategies
13.18. LabCorp diagnostics
13.18.1. Company Snapshot
13.18.2. Overview
13.18.3. Financial Overview
13.18.4. Product Portfolio
13.18.5. Key Developments
13.18.6. Strategies
13.19. Myriad
13.19.1. Company Snapshot
13.19.2. Overview
13.19.3. Financial Overview
13.19.4. Product Portfolio
13.19.5. Key Developments
13.19.6. Strategies
13.20. Natera
13.20.1. Company Snapshot
13.20.2. Overview
13.20.3. Financial Overview
13.20.4. Product Portfolio
13.20.5. Key Developments
13.20.6. Strategies
13.21. PacBio
13.21.1. Company Snapshot
13.21.2. Overview
13.21.3. Financial Overview
13.21.4. Product Portfolio
13.21.5. Key Developments
13.21.6. Strategies
13.22. Pathway Genomics
13.22.1. Company Snapshot
13.22.2. Overview
13.22.3. Financial Overview
13.22.4. Product Portfolio
13.22.5. Key Developments
13.22.6. Strategies
13.23. Qiagen
13.23.1. Company Snapshot
13.23.2. Overview
13.23.3. Financial Overview
13.23.4. Product Portfolio
13.23.5. Key Developments
13.23.6. Strategies
13.24. Roche Diagnostic
13.24.1. Company Snapshot
13.24.2. Overview
13.24.3. Financial Overview
13.24.4. Product Portfolio
13.24.5. Key Developments
13.24.6. Strategies
13.25. Others
13.25.1. Company Snapshot
13.25.2. Overview
13.25.3. Financial Overview
13.25.4. Product Portfolio
13.25.5. Key Developments
13.25.6. Strategies

Section 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

Request to Buy This Premium Report From here@ https://www.visionresearchreports.com/report/cart/28947